| Website | airxpanders.com |
| Category | BioTech |
| Phone | 650-390-9000 |
| info@airxpanders.com | |
| Employees | |
| Founded | 2006 |
| TOTAL | $26M |
| FUNDING TOTAL | $26M |
| Venture Round, 12/06 Heron Capital Prolog Ventures | $4M |
| Venture Round, 3/11 GBS Ventures | $5M |
| Venture Round, 3/11 Oxford Finance Corporation | $3M |
| Series D, 1/12 Vivo Ventures GBS Ventures Prolog Ventures Heron Capital | $10M |
| Venture Round, 6/13 | $4M |
AirXpanders is developing technology to address current unmet needs for patients who require tissue expansion after reconstructive surgery with the first emphasis in breast reconstruction. Present methods of tissue expansion utilize saline filled implants that are typically injected on a weekly basis after surgery in order to reach the volume of skin and tissue required for the placement of a permanent breast implant.